Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00287105||Completed||Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children||
||Other / Industry||
||49||All||1 Year to 18 Years (Child, Adult)||NCT00287105||EUDRACT 2004-001647-30
|ESPHALL||December 2005||March 30, 2016||March 3, 2017||February 6, 2006||October 20, 2017||